• Adia Med partnered with Live Oak Health, operating as QCM Biologics, in 2026.
• The partnership included a 30% stake sale in Adia Labs for $1.5 million.
• Adia Labs sells exclusively to master distributors, including QCM Biologics, under its current operating structure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Med Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611090800NEWSFILECNPR____20261109_322882_1) on November 09, 2026, and is solely responsible for the information contained therein.